Clinical Research

Clinical Trials in Multiple Sclerosis:

The Role of Gut Bacteria (microbiome) in Multiple Sclerosis: Suhayl Dhib Jalbut, MD & Kouichi Ito, PhD

Cognitive Rehabilitation in Multiple Sclerosis: Jasdeep Hundal, MD, Vikram Bhise, MD & Suhayl Dhib-Jalbut, MD

Clinical Trials in Movement Disorder:

CHID Enroll-HD: A Prospective Registry Study in Global Huntington's Disease Cohort

Clinical Trials in Epilepsy:

SLATE The purpose of the study is to evaluate the safety and efficacy of the Visualase MRI-guided laser ablation system for necrotization or coagulation of epileptogenic foci in patients with intractable mesial temporal lobe epilepsy.

Pivotal-Safety and Therapeutic Measures of tDCS in Patients with Refractory Focal Epilepsy This is a multiple site, randomized, double blinded parallel-group controlled study. The purpose of this study is to evaluate efficacy, safety, and tolerability of repeated, daily sessions with the STARSTIM device, which delivers transcranial cathodal direct current stimulation (tDCS). 

Clinical Trials in Neurocognitive/Behavioral:

  • Long COVID and Memory: Our post-COVID research seeks to better understand long COVID symptoms, especially those related to memory and thinking (“brain fog”). We believe that inflammation related to the initial COVID-19 continues to impact some people’s memory and thinking and are seeking to understand why some people go onto develop these persistent symptoms, while others do not.
    • Eligibility: Any adults (18+) that have experienced a COVID-19 infection are eligible to participate, regardless of if they have Long COVID symptoms. 
  • Memory and Aging Study: this study seeks to better understand aging & dementia.
    • Eligibility: Healthy middle-aged and older adults, as well as people with memory and thinking problems due to: mild Alzheimer’s, frontotemporal dementia, or ALS (Lou Gehrig’s disease).
  • South Asian Brain Health Study: This study seeks to better understand patterns of aging in people of South Asian descent and how brain aging differs between people. To participate, you'll be invited to our research center in Piscataway, NJ to have a brain MRI and perform memory and thinking activities guided by one of our research staff members. Participants will also be sent an email link to complete online surveys.
    • Eligibility: You may be eligible to participate if you are of South Asian descent, over 60-years old and English-speaking.

Study Contact (for all listed above): Alice Dawson, M.A., phone: 732-595-6336, email:

Clinical Trials in Neuromuscular Diseases:

    Clinical Trials in Stroke:

    CHARM: Phase 3 Study to Evaluate the Efficavy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction (CHARM)

    Stroke Rehabilitation Reasearch Project: Testing early initiation of neuro rehabilitation on its impact on reduced hospital length of stay, hospital readmission rate, and improvement on long term follow up. PI: Dr. Kiwon Lee